{"id":2042,"date":"2017-07-24T14:02:33","date_gmt":"2017-07-24T12:02:33","guid":{"rendered":"http:\/\/lbti.ibcp.fr\/?page_id=2042"},"modified":"2025-07-28T16:04:08","modified_gmt":"2025-07-28T14:04:08","slug":"publications-pole-prabi-2","status":"publish","type":"page","link":"https:\/\/lbti.ibcp.fr\/?page_id=2042","title":{"rendered":"Publications EcMo"},"content":{"rendered":"88 publications founded.
2025<\/a>
88.<\/b><\/font>\u00a0\u00a0Rhodamine6G and H\u0153chst33342 narrow BmrA conformational spectrum for a more efficient use of ATP.<\/b><\/font>\u00a0
Gobet A, Moissonnier L, Zarkadas E, Magnard S, Bettler E, Martin J, Terreux R, Schoehn G, Orelle C, Jault Jm, Falson P, Chaptal V
(2025)\u00a0Nat Commun<\/b>\u00a016<\/u> :1745-1745\u00a0\u00a0![\"Icon](\"\/img\/smallpubmed.gif\")
<\/a>
87.<\/b><\/font>\u00a0\u00a0Author Correction: Pharmacogenomic screening identifies and repurposes leucovorin and dyclonine as pro-oligodendrogenic compounds in brain repair.<\/b><\/font>\u00a0
Hur\u00e9 Jb, Foucault L, Ghayad Lm, Marie C, Vachoud N, Baudouin L, Azmani R, Ivljanin N, Arevalo-nuevo A, Pigache M, Bouslama-oueghlani L, Chemelle Ja, Dronne Ma, Terreux R, Hassan B, Gueyffier F, Raineteau O, Parras C
(2025)\u00a0Nat Commun<\/b>\u00a016<\/u> :538-538\u00a0\u00a0<\/a>
2024<\/a>
86.<\/b><\/font>\u00a0\u00a0Design, synthesis, and structure-activity relationship studies of 6H-benzo[b]indeno[1,2-d]thiophen-6-one derivatives as DYRK1A\/CLK1\/CLK4\/haspin inhibitors.<\/b><\/font>\u00a0
Faouzi A, Arnaud A, Hall\u00e9 F, Roussel J, Aymard M, Denavit V, Do Cv, Mularoni A, Salah M, Elhady A, Pham Tn, Bancet A, Le Borgne M, Terreux R, Barret R, Engel M, Lomberget T
(2024)\u00a0Rsc Med Chem<\/b>\u00a016<\/u> :179-199\u00a0\u00a0<\/a>
85.<\/b><\/font>\u00a0\u00a0Pharmacogenomic screening identifies and repurposes leucovorin and dyclonine as pro-oligodendrogenic compounds in brain repair.<\/b><\/font>\u00a0
Hur\u00e9 Jb, Foucault L, Ghayad Lm, Marie C, Vachoud N, Baudouin L, Azmani R, Ivljanin N, Arevalo-nuevo A, Pigache M, Bouslama-oueghlani L, Chemelle Ja, Dronne Ma, Terreux R, Hassan B, Gueyffier F, Raineteau O, Parras C
(2024)\u00a0Nat Commun<\/b>\u00a015<\/u> :9837-9837\u00a0\u00a0<\/a>
2023<\/a>
84.<\/b><\/font>\u00a0\u00a0Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against hepatitis B virus.<\/b><\/font>\u00a0
Lamrayah M, Charriaud F, Desmares M, Coiffier C, Megy S, Colomb E, Terreux R, Lucifora J, Durantel D, Verrier B
(2023)\u00a0Antiviral Res<\/b>\u00a0209<\/u> :105483-105483\u00a0\u00a0<\/a>
83.<\/b><\/font>\u00a0\u00a0Identification of PCPE-2 as the endogenous specific inhibitor of human BMP-1\/tolloid-like proteinases.<\/b><\/font>\u00a0
Vadon-le Goff S, Tessier A, Napoli M, Dieryckx C, Bauer J, Dussoyer M, Lagoutte P, Peyronnel C, Essayan L, Kleiser S, Tueni N, Bettler E, Mariano N, Errazuriz-cerda E, Fruchart Gaillard C, Ruggiero F, Becker-pauly C, Allain Jm, Bruckner-tuderman L, Nystr\u00f6m A, Moali C
(2023)\u00a0Nat Commun<\/b>\u00a014<\/u> :8020-8020\u00a0\u00a0<\/a>
2021<\/a>
82.<\/b><\/font>\u00a0\u00a0Discovery of a Novel Non-Narcotic Analgesic Derived from the CL-20 Explosive: Synthesis, Pharmacology, and Target Identification of Thiowurtzine, a Potent Inhibitor of the Opioid Receptors and the Ion Channels.<\/b><\/font>\u00a0
Aguero S, Megy S, Eremina Vv, Kalashnikov Ai, Krylova Sg, Kulagina Da, Lopatina Ka, Fournier M, Povetyeva Tn, Vorozhtsov Ab, Sysolyatin Sv, Zhdanov Vv, Terreux R
(2021)\u00a0Acs Omega<\/b>\u00a06<\/u> :15400-15411\u00a0\u00a0<\/a>
81.<\/b><\/font>\u00a0\u00a0Latent TGF-\u03b2 Activation Is a Hallmark of the Tenascin Family.<\/b><\/font>\u00a0
Aubert A, Mercier-gouy P, Aguero S, Berthier L, Liot S, Prigent L, Alcaraz Lb, Verrier B, Terreux R, Moali C, Lambert E, Valcourt U
(2021)\u00a0Front Immunol<\/b>\u00a012<\/u> :613438-613438\u00a0\u00a0<\/a>
80.<\/b><\/font>\u00a0\u00a0Surface charge modulation of rifampicin-loaded PLA nanoparticles to improve antibiotic delivery in Staphylococcus aureus biofilms.<\/b><\/font>\u00a0
Da Costa D, Exbrayat-h\u00e9ritier C, Rambaud B, Megy S, Terreux R, Verrier B, Primard C
(2021)\u00a0J Nanobiotechnology<\/b>\u00a019<\/u> :12-12\u00a0\u00a0<\/a>
79.<\/b><\/font>\u00a0\u00a0Uncompetitive nanomolar dimeric indenoindole inhibitors of the human breast cancer resistance pump ABCG2.<\/b><\/font>\u00a0
Guragossian N, Belhani B, Moreno A, Nunes Mt, Gonzalez-lobato L, Marminon C, Berthier L, Rocio Andrade Pires Ad, \u00d6zvegy-laczka C, Sarkadi B, Terreux R, Bouaziz Z, Berredjem M, Jose J, Di Pietro A, Falson P, Le Borgne M
(2021)\u00a0Eur J Med Chem<\/b>\u00a0211<\/u> :113017-113017\u00a0\u00a0<\/a>
78.<\/b><\/font>\u00a0\u00a0Procollagen C-proteinase enhancer-1 (PCPE-1), a potential biomarker and therapeutic target for fibrosis.<\/b><\/font>\u00a0
Lagoutte P, Bettler E, Vadon-le Goff S, Moali C
(2021)\u00a0Matrix Biol Plus<\/b>\u00a011<\/u> :100062-100062\u00a0\u00a0<\/a>
2020<\/a>
77.<\/b><\/font>\u00a0\u00a0Construction of atomic models of full hepatitis B vaccine particles at different stages of maturation.<\/b><\/font>\u00a0
Berthier L, Brass O, Deleage G, Terreux R
(2020)\u00a0J Mol Graph Model<\/b>\u00a098<\/u> :107610-107610\u00a0\u00a0<\/a>
76.<\/b><\/font>\u00a0\u00a0Molecular Dynamics Studies of Poly(Lactic Acid) Nanoparticles and Their Interactions with Vitamin E and TLR Agonists Pam1<\/sub>CSK4<\/sub> and Pam3<\/sub>CSK4<\/sub>.<\/b><\/font>\u00a0
Megy S, Aguero S, Da Costa D, Lamrayah M, Berthet M, Primard C, Verrier B, Terreux R
(2020)\u00a0Nanomaterials (basel)<\/b>\u00a010<\/u> :\u00a0\u00a0<\/a>
2019<\/a>
75.<\/b><\/font>\u00a0\u00a0COL1A1 C-propeptide mutations cause ER mislocalization of procollagen and impair C-terminal procollagen processing.<\/b><\/font>\u00a0
Barnes Am, Ashok A, Makareeva En, Brusel M, Cabral Wa, Weis M, Moali C, Bettler E, Eyre Dr, Cassella Jp, Leikin S, Hulmes Djs, Kessler E, Marini Jc
(2019)\u00a0Biochim Biophys Acta Mol Basis Dis<\/b>\u00a0<\/u> :\u00a0\u00a0<\/a>
74.<\/b><\/font>\u00a0\u00a0Molecular modelling of TLR agonist Pam(3)CSK(4) entrapment in PLA nanoparticles as a tool to explain loading efficiency and functionality.<\/b><\/font>\u00a0
Lamrayah M, Charriaud F, Hu S, Megy S, Terreux R, Verrier B
(2019)\u00a0Int J Pharm<\/b>\u00a0568<\/u> :118569-118569\u00a0\u00a0<\/a>
2018<\/a>
73.<\/b><\/font>\u00a0\u00a0Structural Basis for the Acceleration of Procollagen Processing by Procollagen C-Proteinase Enhancer-1.<\/b><\/font>\u00a0
Pulido D, Sharma U, Vadon-le Goff S, Hussain Sa, Cordes S, Mariano N, Bettler E, Moali C, Aghajari N, Hohenester E, Hulmes Djs
(2018)\u00a0Structure<\/b>\u00a0<\/u> :\u00a0\u00a0<\/a>
72.<\/b><\/font>\u00a0\u00a0In Silico, in Vitro, and in Vivo Evaluation of New Candidates for ?-Synuclein PET Imaging.<\/b><\/font>\u00a0
Verdurand M, Levigoureux E, Zeinyeh W, Berthier L, Mendjel-herda M, Cadarossanesaib F, Bouillot C, Iecker T, Terreux R, Lancelot S, Chauveau F, Billard T, Zimmer L
(2018)\u00a0Mol Pharm<\/b>\u00a015<\/u> :3153-3166\u00a0\u00a0<\/a>
2017<\/a>
71.<\/b><\/font>\u00a0\u00a0Ames test prediction on High Energy Molecules by On-The-Fly QSAR (OTF-QSAR)<\/b><\/font>\u00a0
Alliod C, Chemelle Ja, Jacob G, Terreux R
(2017)\u00a0Propellants, Explosives, Pyrotechnics<\/b>\u00a042<\/u> :24-35
70.<\/b><\/font>\u00a0\u00a0Destabilization of the TWIST1\/E12 complex dimerization following the R154P point-mutation of TWIST1: an in silico approach.<\/b><\/font>\u00a0
Bouard C, Terreux R, Tissier A, Jacqueroud L, Vigneron A, Ansieau S, Puisieux A, Payen L
(2017)\u00a0Bmc Struct Biol<\/b>\u00a017<\/u> :6-6\u00a0\u00a0<\/a>
2016<\/a>
69.<\/b><\/font>\u00a0\u00a0Deciphering the molecular mechanisms underlying the binding of the TWIST1\/E12 complex to regulatory E-box sequences.<\/b><\/font>\u00a0
Bouard C, Terreux R, Honorat M, Manship B, Ansieau S, Vigneron Am, Puisieux A, Payen L
(2016)\u00a0Nucleic Acids Res<\/b>\u00a044<\/u> :5470-89\u00a0\u00a0<\/a>
68.<\/b><\/font>\u00a0\u00a0Bioinspired Design and Oriented Synthesis of Immunogenic Site-Specifically Penicilloylated Peptides.<\/b><\/font>\u00a0
Scornet N, Delarue-cochin S, Azoury Me, Le Mignon M, Chemelle Ja, Nony E, Maillere B, Terreux R, Pallardy M, Joseph D
(2016)\u00a0Bioconjug Chem<\/b>\u00a027<\/u> :2629-2645\u00a0\u00a0<\/a>
67.<\/b><\/font>\u00a0\u00a0Unsymmetrical alpha,omega-end-functionalized oligo(cyclohexylidenes): efficient synthesis and conformational analysis<\/b><\/font>\u00a0
Zeinyeh W, Radix S, Terreux R, Chemelle Ja, Walchshofer N
(2016)\u00a0Tetrahedron<\/b>\u00a072<\/u> :4032-4038
2015<\/a>
66.<\/b><\/font>\u00a0\u00a0A Novel Alpha Cardiac Actin (ACTC1) Mutation Mapping to a Domain in Close Contact with Myosin Heavy Chain Leads to a Variety of Congenital Heart Defects, Arrhythmia and Possibly Midline Defects.<\/b><\/font>\u00a0
Augiere C, Megy S, El Malti R, Boland A, El Zein L, Verrier B, Megarbane A, Deleuze Jf, Bouvagnet P
(2015)\u00a0Plos One<\/b>\u00a010<\/u> :e0127903-e0127903\u00a0\u00a0<\/a>
65.<\/b><\/font>\u00a0\u00a0Active site coupling in Plasmodium falciparum GMP synthetase is triggered by domain rotation.<\/b><\/font>\u00a0
Ballut L, Violot S, Shivakumaraswamy S, Thota Lp, Sathya M, Kunala J, Dijkstra Bw, Terreux R, Haser R, Balaram H, Aghajari N
(2015)\u00a0Nat Commun<\/b>\u00a06<\/u> :8930-8930\u00a0\u00a0<\/a>
64.<\/b><\/font>\u00a0\u00a0A purified truncated form of yeast Gal4 expressed in Escherichia coli and used to functionalize poly(lactic acid) nanoparticle surface is transcriptionally active in cellulo.<\/b><\/font>\u00a0
Legaz S, Exposito Jy, Borel A, Candusso Mp, Megy S, Montserret R, Lahaye V, Terzian C, Verrier B
(2015)\u00a0Protein Expr Purif<\/b>\u00a0113<\/u> :94-101\u00a0\u00a0<\/a>
63.<\/b><\/font>\u00a0\u00a0Quantification and kinetic study in plasma and tissues of (E)-1,1,4,4-tetramethyl-2-tetrazene, a liquid propellant and a transformation product of 1,1-dimethyl hydrazine.<\/b><\/font>\u00a0
Payen L, Honorat M, Bouard C, Jacob G, Terreux R, Delalu H, Labarthe E, Guitton J
(2015)\u00a0Anal Bioanal Chem<\/b>\u00a0407<\/u> :6721-9\u00a0\u00a0<\/a>
2014<\/a>
62.<\/b><\/font>\u00a0\u00a0Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication.<\/b><\/font>\u00a0
Berger C, Romero-brey I, Radujkovic D, Terreux R, Zayas M, Paul D, Harak C, Hoppe S, Gao M, Penin F, Lohmann V, Bartenschlager R
(2014)\u00a0Gastroenterology<\/b>\u00a0147<\/u> :1094-1105\u00a0\u00a0<\/a>
61.<\/b><\/font>\u00a0\u00a0Interhelical loops within the bHLH domain are determinant in maintaining TWIST1-DNA complexes.<\/b><\/font>\u00a0
Bouard C, Terreux R, Hope J, Chemelle Ja, Puisieux A, Ansieau S, Payen L
(2014)\u00a0J Biomol Struct Dyn<\/b>\u00a032<\/u> :226-41\u00a0\u00a0<\/a>
60.<\/b><\/font>\u00a0\u00a0Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux.<\/b><\/font>\u00a0
Lorendeau D, Dury L, Genoux-bastide E, Lecerf-schmidt F, Simoes-pires C, Carrupt Pa, Terreux R, Magnard S, Di Pietro A, Boumendjel A, Baubichon-cortay H
(2014)\u00a0Biochem Pharmacol<\/b>\u00a090<\/u> :235-45\u00a0\u00a0<\/a>
59.<\/b><\/font>\u00a0\u00a0MBL-II-141, a chromone derivative, enhances irinotecan (CPT-11) anticancer efficiency in ABCG2-positive xenografts.<\/b><\/font>\u00a0
Payen L, Honorat M, Guitton J, Gauthier C, Bouard C, Lecerf-schmidt F, Peres B, Terreux R, Gervot H, Rioufol C, Boumendjel A, Puisieux A, Di Pietro A
(2014)\u00a0Oncotarget<\/b>\u00a05<\/u> :11957-70\u00a0\u00a0<\/a>
58.<\/b><\/font>\u00a0\u00a0Quinoxaline-substituted chalcones as new inhibitors of breast cancer resistance protein ABCG2: polyspecificity at B-ring position.<\/b><\/font>\u00a0
Winter E, Gozzi Gj, Chiaradia-delatorre Ld, Daflon-yunes N, Terreux R, Gauthier C, Mascarello A, Leal Pc, Cadena Sm, Yunes Ra, Nunes Rj, Creczynski-pasa Tb, Di Pietro A
(2014)\u00a0Drug Des Devel Ther<\/b>\u00a08<\/u> :609-19\u00a0\u00a0<\/a>
2013<\/a>
57.<\/b><\/font>\u00a0\u00a0Calcineurin A versus NS5A-TP2\/HD domain containing 2: a case study of site-directed low-frequency random mutagenesis for dissecting target specificity of peptide aptamers.<\/b><\/font>\u00a0
Dibenedetto S, Cluet D, Stebe Pn, Baumle V, Leault J, Terreux R, Bickle M, Chassey Bd, Mikaelian I, Colas P, Spichty M, Zoli M, Rudkin Bb
(2013)\u00a0Mol Cell Proteomics<\/b>\u00a012<\/u> :1939-52\u00a0\u00a0<\/a>
56.<\/b><\/font>\u00a0\u00a0Localization of putative binding sites for cyclic guanosine monophosphate and the anti-cancer drug 5-fluoro-2'-deoxyuridine-5'-monophosphate on ABCC11 in silico models.<\/b><\/font>\u00a0
Honorat M, Terreux R, Falson P, Di Pietro A, Dumontet C, Payen L
(2013)\u00a0Bmc Struct Biol<\/b>\u00a013<\/u> :7-7\u00a0\u00a0<\/a>
55.<\/b><\/font>\u00a0\u00a0New structure-activity relationships of chalcone inhibitors of breast cancer resistance protein: polyspecificity toward inhibition and critical substitutions against cytotoxicity.<\/b><\/font>\u00a0
Rangel Lp, Winter E, Gauthier C, Terreux R, Chiaradia-delatorre Ld, Mascarello A, Nunes Rj, Yunes Ra, Creczynski-pasa Tb, Macalou S, Lorendeau D, Baubichon-cortay H, Ferreira-pereira A, Di Pietro A
(2013)\u00a0Drug Des Devel Ther<\/b>\u00a07<\/u> :1043-52\u00a0\u00a0<\/a>
2012<\/a>
54.<\/b><\/font>\u00a0\u00a0Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity.<\/b><\/font>\u00a0
Valdameri G, Gauthier C, Terreux R, Kachadourian R, Day Bj, Winnischofer Sm, Rocha Me, Frachet V, Ronot X, Di Pietro A, Boumendjel A
(2012)\u00a0J Med Chem<\/b>\u00a055<\/u> :3193-200\u00a0\u00a0<\/a>
53.<\/b><\/font>\u00a0\u00a06-halogenochromones bearing tryptamine: one-step access to potent and highly selective inhibitors of breast cancer resistance protein.<\/b><\/font>\u00a0